Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001654448-15-000002
Filing Date
2015-09-30
Accepted
2015-09-30 10:59:51
Documents
1
Effectiveness Date
2015-09-30
Items
Item 04: Rule 504(b)(1) (not (i), (ii) or (iii))

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 4850
  Complete submission text file 0001654448-15-000002.txt   5946
Mailing Address 55 MADISON STREET SUITE 400 MORRISTOWN NJ 07960
Business Address 55 MADISON STREET SUITE 400 MORRISTOWN NJ 07960 940-391-3540
Alitair Pharmaceuticals, Inc. (Filer) CIK: 0001654448 (see all company filings)

EIN.: 272999493 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-248476 | Film No.: 151133008